Company Filing History:
Years Active: 2018-2020
Title: Jay Matthew West: Innovator in N-acylethanolamine Hydrolyzing Acid Amidase Inhibitors
Introduction
Jay Matthew West is a notable inventor based in Boston, MA. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for N-acylethanolamine hydrolyzing acid amidase (NAAA). With a total of two patents to his name, West's work is paving the way for advancements in therapeutic applications.
Latest Patents
West's latest patents focus on N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors. These compounds are represented as Formula I, including their tautomeric and stereoisomeric forms, as well as pharmaceutically acceptable salts. The compounds of Formula I serve as inhibitors of NAAA, which is crucial for treating conditions mediated by this enzyme. The technology encompasses compounds, compositions, and methods aimed at inhibiting NAAA and addressing related medical conditions.
Career Highlights
Jay Matthew West is affiliated with Northeastern University, where he engages in research and development related to his patents. His work is instrumental in exploring new therapeutic avenues and enhancing our understanding of biochemical processes.
Collaborations
West collaborates with esteemed colleagues, including Michael Sotirios Malamas and Alexandros Makriyannis. These partnerships contribute to the innovative research environment at Northeastern University.
Conclusion
Jay Matthew West's contributions to the field of biochemistry through his patents on N-acylethanolamine hydrolyzing acid amidase inhibitors highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.